Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

TC-G 1001, Tocris Bioscience™

Catalog No. p-4816750 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

GPR35 agonist; more potent than zaprinast (Cat. No. 0947)

GPR35 agonist (pEC50 values are 7.59 and 8.36 for β-arrestin and Gαq-i5 Ca2+ assays respectively). Displays 1000-fold greater potency at human GPR35 receptors relative to mouse and rat GPR35 orthologs in an IP1 accumulation assay. More potent than zaprinast (Cat. No. 0947).

Chemical Identifiers

CAS 494191-73-0
Molecular Formula C17H11FN2O3S
Molecular Weight (g/mol) 342.344
InChI Key SYCKPHBALHXMIR-ZROIWOOFSA-N
Synonym 4-2-2-fluorophenyl azamethylene-4-oxo-1,3-thiazolidin-5-ylidene methyl be nzoic acid, 4-z-2-2-fluoroanilino-4-oxo-1,3-thiazol-5-ylidene methyl benzoic acid, 4-2-2-fluorophenyl amino-4-oxo-5 4h-thiazolylidene methyl benzoic acid, 4-2-2-fluoro-phenylimino-4-oxo-thiazolidin-5-ylidenemethyl-benzoic acid, 4-z-2z-2-2-fluorophenyl imino-4-oxo-1,3-thiazolidin-5-ylidene methyl benzoic acid, 4-2z,5z-2-2-fluorophenyl imino-4-oxo-1,3-thiazolidin-5-ylidene methyl benzoic acid
PubChem CID 5766343
IUPAC Name 4-[(Z)-[2-(2-fluoroanilino)-4-oxo-1,3-thiazol-5-ylidene]methyl]benzoic acid
SMILES C1=CC=C(C(=C1)NC2=NC(=O)C(=CC3=CC=C(C=C3)C(=O)O)S2)F

Specifications

Quantity 10 mg
Formula Weight 342.34
Percent Purity >98%
Chemical Name or Material TC-G 1001
Recommended Storage Store at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.